Collaboration. That word was used many times this week as @AtriCure leaders gathered in person to align and launch 2023. We will make a difference for more than 100,000 patients this year, and that will take all of us working together on one mission. Can’t wait to get started!
We’re proud to support the @EACTS Women in Cardiothoracic Surgery Committee. The #WiCTS group will organize a webinar series on “The changing face of leadership: moving from diversity to inclusion,“ starting Sept. 15. Learn more & register: https://t.co/PC1FLGUJP8. #CardioTwitter
It was courageous and generous of @AtriCure’s @p2simons to engage and educate others about heart health by sharing her story and leading today’s 2022 @HeartAssocMN Go Red for Women Evening of Empowerment. #ThankYou
As a team, we are proud to partner with @HeartAssocMN and help in leading many of their initiatives. This year’s Twin Cities Go Red For Women campaign is chaired by our very own Pam Simons! With so many important reasons for championing the cause, Pam shares her ‘why’.
Proud to be celebrating 21 years! We’ve grown a lot in that time, adding new and brilliant minds to the team, introducing new products and therapies to the market, and helping to make a difference in patient lives all over the world.
Today we announced that the FDA has approved #AtriCure’s Hybrid AF Therapy to treat patients with long-standing persistent #Afib. Thank you to the many experts who work tirelessly to discover safe, effective solutions for patients. #clinsci#patientsfirst
https://t.co/JvZHKrrq8J
Today begins #Afib Awareness Month. Atrial fibrillation can be a dangerous condition and is a leading cause of #stroke. RT to help us spread awareness of this undertreated and potentially dangerous condition. https://t.co/X4spk7F5T3#FactsAboutAfib
The AtriClip™ line of devices built to exclude the #LAA from the atrium has a 97% closure rate. See a demo and more in this year’s #AATS2020 Mini Theaters. #AtriCure@AATSHQ
We stand alongside @American_Heart and their efforts toward fighting heart disease and stroke. Last night #AtriCure leaders were honored to attend the @HeartAssocMN Heart Ball. #MHHearts
We’re excited that our AtriClip Flex·V and PRO·V device for left atrial appendage management have received the CE Mark. These AtriClip devices exclude the #LAA with its innovative one-handed application, suture-less clip deployment and tip-first closure. Come see it @EACTS!
Very excited about the opportunities ahead as we announce our intent to acquire SentreHEART. We’re adding to our powerful portfolio as we pursue our mission to fight Afib. @amazetrial@Sentre_Lariat
https://t.co/vVATQyGRe1
I always love to spend time with our world-class #customerservice team. They ensure our products get to the hospitals for the patients who need them, when they need them! Thank you for your hard work and bringing such a positive attitude every day!
Today, I’m incredibly excited to announce one of the innovations that we have been working toward: a device solely dedicated to block pain by temporarily ablating peripheral nerves – the #cryoSPHERE probe. https://t.co/Nyu0rRKRiv #painmanagement